[Federal Register Volume 68, Number 31 (Friday, February 14, 2003)]
[Notices]
[Pages 7569-7570]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-3617]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Board of Scientific Counselors, National Cancer Institute.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would

[[Page 7570]]

constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute, Subcommittee 1--Clinical Sciences and 
Epidemiology.
    Date: March 3-4, 2003.
    Open: March 3, 2003, 8 a.m. to 10:05 a.m.
    Agenda: Joint session of NCI, Board of Scientific Advisors and 
BSC Committees.
    Place: National Institutes of Health, National Cancer Institute, 
9000 Rockville Pike, Bldg. 31, Conference Room 10, Bethesda, MD 
20892.

    Closed: March 3, 2003, 10:05 a.m. to 11:05 a.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, National Cancer Institute, 
9000 Rockville Pike, Building 31, Conference Room 6, Bethesda, MD 
20892.

    Closed: March 3, 2003, 11:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 
20814.

    Closed: March 4, 2003, 8 a.m. to 2 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: Abby B. Sandler, PhD, Scientific Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, Room 2114, Rockville, MD 20852, (301) 496-7628.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by nongovernment 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 6, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-3617 Filed 2-13-03; 8:45 am]
BILLING CODE 4140-01-M